Who is sponsoring NCT04314128?

NCT04314128 is sponsored by Danish Headache Center.

What drugs are being tested in NCT04314128?

Interventions in NCT04314128: TOS and TCD.

What condition does NCT04314128 study?

NCT04314128 studies Idiopathic Intracranial Hypertension.

Is NCT04314128 still recruiting?

NCT04314128 is currently completed. Last updated 7 March 2023.

Last reviewed 2023-03-07 · How we verify

NCT04314128

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessment of ICP in Idiopathic Intracranial Hypertension Using Transocular Ultrasound and Transcranial Doppler

Completed NA Last updated 7 March 2023

What this trial tests

NA trial testing TOS and TCD in Idiopathic Intracranial Hypertension in 78 participants. Completed in 1 February 2023.

Timeline

1 January 2020

Primary endpoint
1 February 2023

1 February 2023

Quick facts

Lead sponsor	Danish Headache Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	78
Start date	1 January 2020
Primary completion	1 February 2023
Estimated completion	1 February 2023
Sites	1 location across Denmark

Drugs / interventions tested

TOS and TCD

Conditions studied

Idiopathic Intracranial Hypertension — all drugs for Idiopathic Intracranial Hypertension →

Sponsor

Danish Headache Center — full company profile →

Who can join

Adults 18 to 65, any sex, with Idiopathic Intracranial Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Idiopathic Intracranial Hypertension (IIH) is a rare disease, primarily affecting overweight females of child-bearing age. Patients suffer from increased intracranial pressure (ICP), typically resulting in headaches, visual disturbances and bilateral papilledema, pulsatile tinnitus and cognitive deficits. The disease is difficult to diagnose, treat and monitor. The only current method of measuring the ICP in day-to-day clinical practice is by lumbar puncture. This procedure is invasive, and often painful for the patient. There is an unmet need of methods that can reliable measure or estimate ICP in a non-invasive manner. Ultrasound is one such potential method, and the aim of this study is to investigate the use of ocular ultrasound and transcranial doppler to measure or estimate ICP.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Idiopathic Intracranial Hypertension

Currently open trials in the same condition.

NCT06855342 — Prospective Ocular Imaging for Intracranial Pressure Evaluation · recruiting
NCT06545981 — Ocular Perfusion in Patients With Idiopathic Intracranial Hypertension · recruiting
NCT06059703 — Biomarkers in the Etiology of Idiopathic Intracranial Hypertension · NA · recruiting
NCT03556085 — Venous Sinus Stenting With the River Stent in IIH · NA · active not recruiting
NCT03096743 — Evaluating Raised Intracranial Pressure Using MR Elastography · NA · active not recruiting

Other Danish Headache Center trials

Trials by the same sponsor.

NCT07451769 — Selective Activation of the Adrenomedullin Receptors in Migraine · NA · not yet recruiting
NCT07342296 — Induction of Migraine Attacks With Aura Using Pituitary Adenylate Cyclase Activating Polypeptide-38 · NA · not yet recruiting
NCT07059546 — Hypersensitivity to Adrenomedullin in Post-Traumatic Headache · NA · recruiting
NCT07021859 — Induction of Migraine Attacks With Aura Using Calcitonin Gene-Related Peptide · NA · recruiting
NCT06959004 — Substance P-Induced Migraine Attacks Without Aura · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04314128 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Danish Headache Center
Last refreshed: 7 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04314128.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing